SCHEMBL4309271

SCHEMBL4309271

Cc1cc(CN(C)C(=O)Cc2c(-c3cccc(Cl)c3Cl)[nH]c3ccc(F)cc23)on1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.38
MLNR O43193 1/20 0.38
CYP3A4 P08684 1/20 0.38
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
CSF1R P07333 1/20 0.37
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
NOS2 P35228 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
HCRTR1 O43613 1/20 0.34
KIF11 P52732 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4311458 0.93 FNTA (0.44) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4304062 0.88 FNTA (0.44) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4310553 0.88 ALDH1A1 (0.40) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4307434 0.86 MLNR (0.39) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4305239 0.86 FNTA (0.45) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4308917 0.86 ALDH1A1 (0.39) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4303720 0.86 FNTA (0.40) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4308341 0.86 FNTA (0.46) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL13881231 0.85 ALDH1A1 (0.38) ALDH1A1KMT2AMLNRCYP3A4FNTA
SCHEMBL4311494 0.85 ALDH1A1 (0.41) ALDH1A1KMT2AMLNRCYP3A4FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088452-A1 Indole Orexin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-04-02 US claimed
US-20090088452-A1 Indole Orexin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-04-02 US disclosed
US-20090088452-A1 Indole Orexin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-04-02 US disclosed
US-20090088452-A1 Indole Orexin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088452-A1 Indole Orexin Receptor Antagonists HCRTR2, HCRTR1, OXTR ALDH1A1 3088/4885KMT2A 934/4885MLNR 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.